This cross-sectional study aimed to assess and compare quality of life in patients with advanced oral cavity tumors after mandibular resection in 3 groups (no reconstruction, reconstruction with plate, and reconstruction with flap) at the Cancer Institute, affiliated to Tehran University of Medical Sciences.
Quality of life was measured using the EuropeanOrganization for Research and Treatment of Cancer core quality of life questionnaire and EuropeanOrganization for Research and Treatment of Cancer head and neck cancer-specific quality of life questionnaire-35 items.
The comparison was tested using Kurskal-Wallis analysis. All 120 patients were entered into the study. The mean age of patients was 48.5 (standard deviation = 18.1) years. Patients presented with advanced stage of the disease and underwent mandibular resection with no reconstruction (n = 40), reconstruction with plate (n = 41), and reconstruction with flap (n = 39).
The findings showed that in general, there were no statistically significant differences in quality of life among 3 groups except for speech problem (P = .4), dry mouth (P = .03), and feeling ill (P = .04).
 SC-PEG-SC |
| abx085129-08kDa1g |
Abbexa |
0.8 kDa; 1 g |
EUR 328.00 |
- Shipped within 5-10 working days.
|
SC-PEG-SC |
| abx085129-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 328.00 |
- Shipped within 5-10 working days.
|
SC-PEG-SC |
| abx085129-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 328.00 |
- Shipped within 5-10 working days.
|
 SC-PEG-SC,10K |
| 33-HO023023-10K |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,1K |
| 33-HO023023-1K |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,20K |
| 33-HO023023-20K |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,2K |
| 33-HO023023-2K |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,3.4K |
| 33-HO023023-3.4K |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,400 |
| 33-HO023023-400 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,4K |
| 33-HO023023-4K |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,500 |
| 33-HO023023-500 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,5K |
| 33-HO023023-5K |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,600 |
| 33-HO023023-600 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,6K |
| 33-HO023023-6K |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 SC-PEG-SC,800 |
| 33-HO023023-800 |
Biochempeg |
|
|
|
Description: A high purity chemical with various applications in medical research, drug-release, nanotechnology and new materials research, cell culture. In the study of ligand, polypeptide synthesis support, a graft polymer compounds, new materials, and polyethylene glycol-modified functional coatings and other aspects of the active compound. |
 5X RIPA Buffer |
| AKR-191 |
Cell Biolabs |
20mL |
EUR 137.00 |
|
Description: RIPA Buffer extracts proteins from cultured mammalian cells for various downstream applications. |
 TBE Buffer, 5X |
| 41006 |
Biotium |
4L |
EUR 111.00 |
|
Description: Minimum order quantity: 1 unit of 4L |
 5X TBE Buffer |
| T8051-100 |
GenDepot |
2X500ml |
EUR 82.00 |
5X TBE Buffer |
| T8051-200 |
GenDepot |
4X500ml |
EUR 107.00 |
 5x Stop Buffer |
| TG4037 |
TopoGen |
1ml |
EUR 156.00 |
 5X Potassium Glutamate |
| TG4055 |
TopoGen |
1ml |
EUR 156.00 |
 SC 57461A |
| A4408-10 |
ApexBio |
10 mg |
EUR 241.00 |
|
Description: SC-57461A is a selective inhibitor of human recombinant LTB4 with IC50 value of 49 nM [1].LTB4 (leukotriene B (4)) is a leukotriene and plays an important role in inflammation. |
SC 57461A |
| A4408-25 |
ApexBio |
25 mg |
EUR 485.00 |
|
Description: SC-57461A is a selective inhibitor of human recombinant LTB4 with IC50 value of 49 nM [1].LTB4 (leukotriene B (4)) is a leukotriene and plays an important role in inflammation. |
SC 57461A |
| A4408-5 |
ApexBio |
5 mg |
EUR 171.00 |
|
Description: SC-57461A is a selective inhibitor of human recombinant LTB4 with IC50 value of 49 nM [1].LTB4 (leukotriene B (4)) is a leukotriene and plays an important role in inflammation. |
 SC 144 |
| A2173-100 |
ApexBio |
100 mg |
EUR 1210.00 |
|
Description: SC144 is an inhibitor of gp130 with IC50 values of 0.43 ?mol/L and 0.88 ?mol/L in NCI/ADR-RES and HEY cell lines, respectively [1].SC144 is a ?rst-in-class small-molecule gp130 inhibitor with oral activity in ovarian cancer. |
SC 144 |
| A2173-25 |
ApexBio |
25 mg |
EUR 456.00 |
|
Description: SC144 is an inhibitor of gp130 with IC50 values of 0.43 ?mol/L and 0.88 ?mol/L in NCI/ADR-RES and HEY cell lines, respectively [1].SC144 is a ?rst-in-class small-molecule gp130 inhibitor with oral activity in ovarian cancer. |
SC 144 |
| A2173-5 |
ApexBio |
5 mg |
EUR 142.00 |
|
Description: SC144 is an inhibitor of gp130 with IC50 values of 0.43 ?mol/L and 0.88 ?mol/L in NCI/ADR-RES and HEY cell lines, respectively [1].SC144 is a ?rst-in-class small-molecule gp130 inhibitor with oral activity in ovarian cancer. |
SC 144 |
| A2173-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 151.00 |
|
Description: SC144 is an inhibitor of gp130 with IC50 values of 0.43 ?mol/L and 0.88 ?mol/L in NCI/ADR-RES and HEY cell lines, respectively [1].SC144 is a ?rst-in-class small-molecule gp130 inhibitor with oral activity in ovarian cancer. |
 Sc-514 |
| abx188875-1g |
Abbexa |
1 g |
EUR 871.00 |
- Shipped within 1-2 weeks.
|
 SC 514 |
| 20-abx076580 |
Abbexa |
|
|
- Shipped within 5-12 working days.
|
 SC 79 |
| 20-abx076733 |
Abbexa |
|
|
- Shipped within 5-12 working days.
|
 mPEG-SC |
| abx085126-075kDa1g |
Abbexa |
0.75 kDa; 1 g |
EUR 328.00 |
- Shipped within 5-10 working days.
|
mPEG-SC |
| abx085126-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 356.00 |
- Shipped within 5-10 working days.
|
mPEG-SC |
| abx085126-1kDa1g |
Abbexa |
1 kDa; 1 g |
EUR 356.00 |
- Shipped within 5-10 working days.
|
mPEG-SC |
| abx085126-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 356.00 |
- Shipped within 5-10 working days.
|
mPEG-SC |
| abx085126-2kDa1g |
Abbexa |
2 kDa; 1 g |
EUR 398.00 |
- Shipped within 5-10 working days.
|
 SC 51089 |
| B7496-10 |
ApexBio |
10 mg |
EUR 229.00 |
SC 51089 |
| B7496-25 |
ApexBio |
25 mg |
EUR 415.00 |
SC 51089 |
| B7496-5 |
ApexBio |
5 mg |
EUR 144.00 |
 SC 236 |
| B7533-10 |
ApexBio |
10 mg |
EUR 224.00 |
SC 236 |
| B7533-5 |
ApexBio |
5 mg |
EUR 154.00 |
SC 236 |
| B7533-50 |
ApexBio |
50 mg |
EUR 833.00 |
 SC 26196 |
| B7608-10 |
ApexBio |
10 mg |
EUR 242.00 |
SC 26196 |
| B7608-25 |
ApexBio |
25 mg |
EUR 485.00 |
SC 26196 |
| B7608-5 |
ApexBio |
5 mg |
EUR 189.00 |
 SC 51322 |
| B5338-10 |
ApexBio |
10 mg |
EUR 216.00 |
SC 51322 |
| B5338-25 |
ApexBio |
25 mg |
EUR 415.00 |
SC 51322 |
| B5338-5 |
ApexBio |
5 mg |
EUR 144.00 |
 SC 58125 |
| B5347-10 |
ApexBio |
10 mg |
EUR 183.00 |
SC 58125 |
| B5347-25 |
ApexBio |
25 mg |
EUR 342.00 |
SC 58125 |
| B5347-5 |
ApexBio |
5 mg |
EUR 125.00 |
 SC 66 |
| B5575-10 |
ApexBio |
10 mg |
EUR 129.00 |
SC 66 |
| B5575-100 |
ApexBio |
100 mg |
EUR 634.00 |
SC 66 |
| B5575-25 |
ApexBio |
25 mg |
EUR 238.00 |
SC 79 |
| B5663-10 |
ApexBio |
10 mg |
EUR 148.00 |
|
Description: IC50: N/ASC 79 is an activator of Akt. Akt/PKB with anti-apoptotic activity (a serine/threonine protein kinase) is one of the major downstream targets of PtdIns P3 signaling pathway. |
SC 79 |
| B5663-50 |
ApexBio |
50 mg |
EUR 334.00 |
|
Description: IC50: N/ASC 79 is an activator of Akt. Akt/PKB with anti-apoptotic activity (a serine/threonine protein kinase) is one of the major downstream targets of PtdIns P3 signaling pathway. |
 SC-514 |
| B1585-10 |
ApexBio |
10 mg |
EUR 108.00 |
|
Description: SC-514 is a cell-permeable and selective inhibitor of IKK-2 with IC50 value of 3-12?M [1, 2].SC-514 inhibits all forms of recombinant human IKK-2 with IC50 values in the 3?12?M range. It also inhibits the native IKK complex. |
SC-514 |
| B1585-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 125.00 |
|
Description: SC-514 is a cell-permeable and selective inhibitor of IKK-2 with IC50 value of 3-12?M [1, 2].SC-514 inhibits all forms of recombinant human IKK-2 with IC50 values in the 3?12?M range. It also inhibits the native IKK complex. |
SC-514 |
| B1585-50 |
ApexBio |
50 mg |
EUR 270.00 |
|
Description: SC-514 is a cell-permeable and selective inhibitor of IKK-2 with IC50 value of 3-12?M [1, 2].SC-514 inhibits all forms of recombinant human IKK-2 with IC50 values in the 3?12?M range. It also inhibits the native IKK complex. |
 SC-10 |
| B6299-10 |
ApexBio |
10 mg |
EUR 213.00 |
SC-10 |
| B6299-50 |
ApexBio |
50 mg |
EUR 744.00 |
 SC-9 |
| B6302-10 |
ApexBio |
10 mg |
EUR 284.00 |
 SC 19220 |
| B6633-10 |
ApexBio |
10 mg |
EUR 216.00 |
SC 19220 |
| B6633-25 |
ApexBio |
25 mg |
EUR 415.00 |
SC 19220 |
| B6633-5 |
ApexBio |
5 mg |
EUR 144.00 |
 SC 560 |
| B6786-10 |
ApexBio |
10 mg |
EUR 177.00 |
|
Description: IC50: 0.009 ?M for COX-1; 6.3 ?M for COX-2SC-560 [5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trif luoromethylpyrazole] is a COX-1-selective inhibitor, which can be used as a pharmacological tool to study the role of COX-1-derived PGs in inflammation and pain. |
SC 560 |
| B6786-25 |
ApexBio |
25 mg |
EUR 328.00 |
|
Description: IC50: 0.009 ?M for COX-1; 6.3 ?M for COX-2SC-560 [5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trif luoromethylpyrazole] is a COX-1-selective inhibitor, which can be used as a pharmacological tool to study the role of COX-1-derived PGs in inflammation and pain. |
SC 560 |
| B6786-5 |
ApexBio |
5 mg |
EUR 119.00 |
|
Description: IC50: 0.009 ?M for COX-1; 6.3 ?M for COX-2SC-560 [5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trif luoromethylpyrazole] is a COX-1-selective inhibitor, which can be used as a pharmacological tool to study the role of COX-1-derived PGs in inflammation and pain. |
SC 560 |
| B6786-5.1 |
ApexBio |
10 mM (in 1mL DMSO) |
EUR 148.00 |
|
Description: IC50: 0.009 ?M for COX-1; 6.3 ?M for COX-2SC-560 [5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trif luoromethylpyrazole] is a COX-1-selective inhibitor, which can be used as a pharmacological tool to study the role of COX-1-derived PGs in inflammation and pain. |
 5x TBE Buffer Solution |
| BA01805 |
Bioatlas |
6x100ml |
EUR 94.00 |
|
Description: High purity buffer for various PCR applications. |
 MangoTaq Buffer 5x, Colourless |
| BIO-37101 |
Bioline |
10ml |
Ask for price |
 MangoTaq Buffer 5x, Coloured |
| BIO-37102 |
Bioline |
10ml |
Ask for price |
 RANGER Reaction Buffer, 5x |
| BIO-37114 |
Bioline |
3 x 1.25ml |
Ask for price |
 MyFi Reaction Buffer, 5x |
| BIO-37115 |
Bioline |
3 x 1.25ml |
Ask for price |
 5X Passive Lysis Buffer |
| 99912 |
Biotium |
30ML |
EUR 77.00 |
|
Description: Minimum order quantity: 1 unit of 30ML |
) 5X Band Sharpener (10ml) |
| 9K-001-0017 |
BBI Biotech |
10mL |
EUR 323.76 |
- Product category: PCR Related/Band Sharpener
|
 Gyrase Assay Buffer 5x |
| TG4030 |
TopoGen |
1ml |
EUR 145.00 |
 Alkyne-PEG-SC |
| abx085263-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 801.00 |
- Shipped within 5-10 working days.
|
Alkyne-PEG-SC |
| abx085263-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 801.00 |
- Shipped within 5-10 working days.
|
Alkyne-PEG-SC |
| abx085263-2kDa1g |
Abbexa |
2 kDa; 1 g |
EUR 801.00 |
- Shipped within 5-10 working days.
|
Alkyne-PEG-SC |
| abx085263-5kDa1g |
Abbexa |
5 kDa; 1 g |
EUR 801.00 |
- Shipped within 5-10 working days.
|
 MA-PEG-SC |
| abx085273-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 718.00 |
- Shipped within 5-10 working days.
|
MA-PEG-SC |
| abx085273-20kDa1g |
Abbexa |
20 kDa; 1 g |
EUR 718.00 |
- Shipped within 5-10 working days.
|
MA-PEG-SC |
| abx085273-2kDa1g |
Abbexa |
2 kDa; 1 g |
EUR 718.00 |
- Shipped within 5-10 working days.
|
MA-PEG-SC |
| abx085273-5kDa1g |
Abbexa |
5 kDa; 1 g |
EUR 718.00 |
- Shipped within 5-10 working days.
|
 CHO-PEG-SC |
| abx085292-10kDa1g |
Abbexa |
10 kDa; 1 g |
EUR 718.00 |
- Shipped within 5-10 working days.
|
Although there were no significant differences in quality of life among patients in 3 groups, overall patients who received reconstruction with flap reported better functioning and fewer symptoms. Those who did not receive any reconstruction reported the worse conditions.
